The role of PARP-2 in inhibiting prostate cancer
Published: 27 Jul 2020
Views: 177
Prof Li Jia - Harvard Medical School, Boston, USA
Prof Li Jia speaks to ecancer about the use of PARP inhibitors in treating prostate cancer.
He talks about the paper he worked on which found that the selective targeting of PARP-2 inhibits androgen receptor signalling and prostate cancer growth. He goes on to discuss the potential of selectively targeting PARP-2 in prostate cancer, particularly in castration-resistant prostate cancer.
Prof Jia explains the differences between PARP-1 and PARP-2, how they are being studied and how that research might be used in the future.
This programme has been supported by an unrestricted educational grant from Pfizer.
Related Videos
PARP inhibitors and prostate cancer: A new era of precision medicine
Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
4 Aug 2020
Oncology pharmacist perspective on PARP inhibitors for castration-resistant pros...
Dr Grace Martin - The University of Kansas Cancer Center, Kansas City, USA
27 Jul 2020
Future perspective of CDH1 mutation in gastric and breast cancers
Dr. Giovanni Corso - University of Milan, Italy, Meeting president
22 Jul 2020
Prophylactic gastrectomy in CDH1 mutation
Prof. Franco Roviello - University of Siena, Italy
22 Jul 2020
Association of BRCA alterations with response to PARP inhibitors in metastatic c...
Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center...
30 May 2020
ASCO GU 2020: Bladder: Genomic profiling, real-world treatment challenges and no...
Dr Petros Grivas, Dr Shilpa Gupta, Dr Alison Birtle and Dr Joseph Jacob
14 Feb 2020
Targeting agent enfortumab vedotin a novel treatment for patients with advanced ...
Prof Daniel Petrylak - Yale Cancer Center, New Haven, USA
3 Jun 2019
New agent targeting Nectin-4 produces responses in nearly half of patients with ...
Prof Daniel Petrylak - Yale Cancer Center, New Haven, USA
3 Jun 2019
Key developments in prostate cancer
Prof Nicholas James, Prof Karim Fizazi, Prof Matthew Smith, Prof Álvaro Pinto an...
22 Oct 2018
